• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Response to: Correspondence on 'Technique and impact on first pass effect primary results of the ASSIST global registry' by Gupta .

作者信息

Gupta Rishi

机构信息

Neurosurgery, WellStar Health System, Marietta, Georgia, USA

出版信息

J Neurointerv Surg. 2024 Jul 5;17(1). doi: 10.1136/jnis-2024-021839.

DOI:10.1136/jnis-2024-021839
PMID:38969495
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11672036/
Abstract
摘要

相似文献

1
Response to: Correspondence on 'Technique and impact on first pass effect primary results of the ASSIST global registry' by Gupta .对古普塔（Gupta）关于“ASSIST全球注册研究的技术及其对首过效应主要结果的影响”的通信的回复
J Neurointerv Surg. 2024 Jul 5;17(1). doi: 10.1136/jnis-2024-021839.
2
Correspondence on 'Technique and impact on first pass effect primary results of the ASSIST global registry' by Gupta .
J Neurointerv Surg. 2024 Jul 14. doi: 10.1136/jnis-2024-021772.
3
COVID-19 Global Rheumatology Alliance Registry, anti-IL-6 therapy, shared decision-making and patient outcomes. Response to: 'Correspondence on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry' by Gianfrancesco . Compassionate use of tocilizumab in severe COVID-19 with hyperinflammation prior to advent of clinical trials - a real-world district general hospital experience' by Khan 'Comment on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 global rheumatology alliance physician-reported registry' by Gianfrancesco M by Andreica and 'COVID-19 outcomes in patients with systemic autoimmune diseases treated with immunomodulatory drugs' by Ansarin .COVID-19全球风湿病联盟注册研究、抗白细胞介素-6治疗、共同决策与患者预后。对以下文章的回应：吉安弗朗切斯科撰写的“风湿病患者COVID-19住院相关特征：来自COVID-19全球风湿病联盟医生报告注册研究的数据”；汗撰写的“在临床试验出现之前，在严重COVID-19伴高炎症中同情使用托珠单抗——一家地区综合医院的真实世界经验”；安德烈伊卡撰写的“对吉安弗朗切斯科·M撰写的‘风湿病患者COVID-19住院相关特征：来自COVID-19全球风湿病联盟医生报告注册研究的数据’的评论”；安萨林撰写的“接受免疫调节药物治疗的系统性自身免疫疾病患者的COVID-19结局” 。
Ann Rheum Dis. 2022 Oct;81(10):e191. doi: 10.1136/annrheumdis-2020-218713. Epub 2020 Aug 12.
4
Technique and impact on first pass effect primary results of the ASSIST global registry.ASSIST全球注册研究的技术及对首过效应的主要影响结果
J Neurointerv Surg. 2025 Jan 17;17(2):128-138. doi: 10.1136/jnis-2023-021126.
5
Correspondence to: 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry' by Gianfrancesco .致信：吉安弗兰切斯科所著的《风湿病患者中与 COVID-19 住院相关的特征：来自 COVID-19 全球风湿病联盟医生报告登记处的数据》
Ann Rheum Dis. 2023 Jun;82(6):e140. doi: 10.1136/annrheumdis-2020-218733. Epub 2020 Aug 19.
6
Rheumatic disease activity, glucocorticoid use and COVID-19. Response to: 'Correspondence on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry' by Gianfrancesco . Disease activity, rather than glucocorticoid therapy, may be associated with COVID-19 severity in patients with rheumatic musculoskeletal diseases' by Giollo .风湿性疾病活动、糖皮质激素使用与2019冠状病毒病。对以下内容的回应：“关于‘风湿性疾病患者2019冠状病毒病住院相关特征：来自2019冠状病毒病全球风湿病联盟医生报告登记处的数据’的通信”，作者为詹弗兰切斯科。乔洛指出：“在风湿性肌肉骨骼疾病患者中，疾病活动而非糖皮质激素治疗可能与2019冠状病毒病的严重程度相关。”
Ann Rheum Dis. 2022 Nov;81(11):e223. doi: 10.1136/annrheumdis-2020-218910. Epub 2020 Sep 7.
7
Correspondence on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 global rheumatology alliance physician-reported registry' by Gianfrancesco M . The impact of cardiovascular comorbidity on COVID-19 infection in a large cohort of rheumatoid arthritis patients.关于吉安弗兰切斯科·M. 的《风湿性疾病患者新冠病毒肺炎住院相关特征：来自新冠病毒肺炎全球风湿病联盟医生报告登记处的数据》的通信。心血管合并症对一大群类风湿关节炎患者新冠病毒感染的影响。
Ann Rheum Dis. 2023 Jul;82(7):e159. doi: 10.1136/annrheumdis-2020-218813. Epub 2020 Sep 15.
8
Response to: Correspondence on 'Clinical value of pre-operative scoring systems to predict leiomyosarcoma: results of a validation study in 177 patients from the NOGGO-REGSA Registry' by Vollmer .对 Vollmer 所著《术前评分系统预测平滑肌肉瘤的临床价值：来自 NOGGO-REGSA 登记处 177 例患者的验证研究结果》的通信回复
Int J Gynecol Cancer. 2022 Jul 4;32(7):964. doi: 10.1136/ijgc-2022-003662.
9
First pass effect in patients with large core infarcts undergoing mechanical thrombectomy: subgroup analysis of the prospective international ASSIST registry.
J Neurointerv Surg. 2025 Jan 8. doi: 10.1136/jnis-2024-022532.
10
Correspondence on 'Clinical value of pre-operative scoring systems to predict leiomyosarcoma: results of a validation study in 177 patients from the NOGGO-REGSA Registry' by Condic .
Int J Gynecol Cancer. 2022 Jul 4;32(7):963. doi: 10.1136/ijgc-2022-003607.

引用本文的文献

1
Tirofiban on First-Pass Recanalization in Acute Stroke Endovascular Thrombectomy: The OPTIMISTIC Randomized Clinical Trial.替罗非班用于急性卒中血管内血栓切除术首次通过再通：OPTIMISTIC随机临床试验
JAMA Netw Open. 2025 Apr 1;8(4):e255308. doi: 10.1001/jamanetworkopen.2025.5308.
2
Trevo 3 Mm and/or AXS Catalyst 5 for the Treatment of Medium Distal Vessel Occlusion Stroke-results from the ASSIST Registry.用于治疗中远端血管闭塞性卒中的Trevo 3毫米和/或AXS Catalyst 5——ASSIST注册研究结果
Clin Neuroradiol. 2025 Mar;35(1):51-57. doi: 10.1007/s00062-024-01450-y. Epub 2024 Aug 23.

本文引用的文献

1
Technique and impact on first pass effect primary results of the ASSIST global registry.ASSIST全球注册研究的技术及对首过效应的主要影响结果
J Neurointerv Surg. 2025 Jan 17;17(2):128-138. doi: 10.1136/jnis-2023-021126.